Author(s):
Sakshi V. Bhope, Suparna S. Bakhle, Juhi M. Makode, Rakshika M. Agrawal, Nikita D. Shukla
Email(s):
bhopesakshi6@gmail.com
DOI:
10.52711/0974-360X.2025.00274 
Address:
Sakshi V. Bhope*, Suparna S. Bakhle, Juhi M. Makode, Rakshika M. Agrawal, Nikita D. Shukla
Department of Pharmaceutics, Priyadarshini J.L. College of Pharmacy, Electronic Zone, MIDC, Hingna, Nagpur, Maharashtra - 440016, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 4,
Year - 2025
ABSTRACT:
ABSTRACT:
Bacterial vaginosis is the most common disease of vagina in the women reproductive age. In the United States, 30% of women who are childbearing age have bacterial vaginosis, a common vaginal infection that reoccurs in 20% to 30% of cases following first treatment. Depletion of important lactobacillus spp., a high species diversity of bacteria, and elevated loads of facultative anaerobes including Atopobium vaginae and Gardnerella vaginalis are characteristics of bacterial vaginosis (BV). In situ gel can be useful for the treatment of bacterial vaginosis as it offers a number of benefits, the most significant of which is its capacity to administer drugs consistently and reliably without compromising visual clarity. Restoring vaginal health with in situ lactobacillus treatment has considerable potential. Consequently, this study provides a quick summary of in situ gel probiotic therapy in combination with mucoadhesive polymer and thermo-responsive polymer for its behaviour and advances in vaginal delivery. This process enhances maximum pharmaceutical potency, duration, penetration, and bioavailability.
Cite this article:
Sakshi V. Bhope, Suparna S. Bakhle, Juhi M. Makode, Rakshika M. Agrawal, Nikita D. Shukla. Mucoadhesive In Situ Gel of Probiotic for the Management of Bacterial Vaginosis: A Review. Research Journal of Pharmacy and Technology. 2025;18(4):1920-4. doi: 10.52711/0974-360X.2025.00274
Cite(Electronic):
Sakshi V. Bhope, Suparna S. Bakhle, Juhi M. Makode, Rakshika M. Agrawal, Nikita D. Shukla. Mucoadhesive In Situ Gel of Probiotic for the Management of Bacterial Vaginosis: A Review. Research Journal of Pharmacy and Technology. 2025;18(4):1920-4. doi: 10.52711/0974-360X.2025.00274 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-4-65
REFERENCES:
1. Kaur M. Vaginal discharge. International Journal of Advances in Nursing Management. 2020; 8 (3); DOI: 10.5958/2454-2652.2020.00057.8
2. Andrade A. Parente M and Ares G. Screening of mucoadhesive vaginal gel formulations. Brazillian Journal of Pharmaceutical Sciences. 2014; 50 (4); http://dx.doi.org/10.1590/S1984-82502014000400029.
3. Sahoo C. Nayak P. Sarangi D. Sahoo T. Intra Vaginal Drug Delivery System: An Overview. American Journal of Advanced Drug Delivery. 2013.
4. Paladine H and Desai U. Vaginitis Diagnosis and treatment. American Academy of Family Physician. 2018; 97 (5).
5. Zhao Y. Wang T. Chen Z. Ren H. Song P. Zhu Y. Liang S and Tzeng C. Development and evaluation of a thermosensitive in situ gel formulation for intravaginal delivery of lactobacillus gasseri. Pharmaceutics. 2022; 14 (1934); DOI:https://doi.org/10.3390/ pharmaceutics14091934.
6. Webb L. Probiotics for preventing recurrent bacterial vaginosis. Journal of American Academy of PAs. 2021; 34 (2); DOI:10.1097/01.JAA.0000731484.81301.58.
7. Patel G. Patel M. Efficacy of novel acid buffering vaginal tablet of metronidazole for bacterial vaginosis. Research Journal of Pharmaceutical Dosage Forms and Technology. 2009; 1(3).
8. Bradshaw C and Brotman R. Making inroads into improving treatment of bacterial vaginosis-striving for long term cure. BioMed Central. 2015; DOI: 10.1186/s12879-015-1027-4.
9. Permana A. Asri R. Amir M. Himawan A. Arjuna A. Juniarti N. Et. al. Development of thermoresponsive hydrogels with mucoadhesive properties loaded with metronidazole Gel- Flakes for improved Bacterial vaginosis treatment. Pharmaceutics. 2023; 15 (1529); https://doi.org /10.3390/ pharmaceutics15051529.
10. Muzny C. Balkus J. Mitchell C. Sobel J. Workowski K. Marrazzo J and Schwebke J. Diagnosis and Management of Bacterial Vaginosis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. Clinical Infectious Diseases. 2022; https://doi.org/10.1093/cid/ciac021.
11. Brown L. Bacterial vaginosis. GP Pharma update. 2019.
12. Coudray M. Madhivanan P. Bacterial Vaginosis - A Brief Synopsis of the Literature. European Journal of Obstetrics Gynecology and Reproductive Biology. 2021; 245: 143–148. doi:10.1016/j.ejogrb.2019.12.035.
13. Dhutwalia P. Kanwar K et.al. A Review on Mucoadhesive drug delivery systems: A novel approach. International Journal of Pharmaceutical. Chemical and Biological Sciences. 2014; 4(2).
14. Mahajan P. Kaur A. Aggarwal G. Harikumar S. Mucoadhesive drug delivery system: A review. International Journal of Drug Development and Research. 2013; 5(1).
15. Boddupalli B. Mohammed Z. Nath R. Banji D. Mucoadhesive drug delivery system: An overview. Journal of Advanced Pharmaceutical Technology & Research. 2010; 1(4); DOI: 10.4103/0110-5558.76436.
16. Kolawole O. Cook M. In situ gelling drug delivery systems for topical drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2023; 184; https://doi.org/10.1016/j.ejpb.2023.01.007.
17. Kurniawansyah I. Rusdiana T. Sopyan I. Arya I. Wahab H and Nurzanah D. Comparative study of in situ gel formulation based on the physico-chemical aspects: Systemic review. Gels. 2023; 9 (645); https:// doi.org/10.3390/gels9080645.
18. Khode P. Dongare P. In situ gel: A review of pharmaceutical and biological evaluation and approaches. Research Journal of Pharmaceutical Dosage Forms and Technology. 2019; 11(3); DOI:10.5958/0975-4377.2019.00037.5.
19. Guven U. Berkman M. Senel B. Yazan Y. Development and in vitro/in vivo evaluation of thermo-sensitive in situ gelling systems for ocular allergy. Brazilian Journal of Pharmaceutical Sciences. 2019; 55:e17511; http://dx.doi.org/10.1590/s2175-97902019000117511
20. Giuliano E. Paolino D. Fresta M and Cosco D. Mucosal applications of poloxamer 407-based hydrogels: An overview. Pharmaceutics. 2018; 10 (159); doi:10.3390/pharmaceutics10030159
21. Mohanty D. Bakshi V. Simharaju N. Haque M. Sahoo C. A review on in situ gel: A novel drug delivery system. International Journal of Pharmaceutical Sciences Review and Research. 2018; 50 (1).
22. Singh A. Kurkure S and Anardi S. Formulation and evaluation of in-situ gelling system for sustained release ophthalmic drug delivery of ciprofloxacin. World Journal of Pharmaceutical Research. 2020; 9(8); DOI: 10.20959/wjpr20208-18075.
23. Konatham M. Gorle M. Pathakala N. Bakshi V. Mamidisetti Y. Chinthakindi P. Jadi R. In situ gel polymer: a review. International Journal of Applied Pharmaceutics. 2020; 13 (1); DOI: http://dx.doi.org/10.22159/ijap.2021v13i1.39504.
24. Dhalkar P. Jagtap S. Jadhav S. Redkar M. Karande B. Formulation and evaluation of in situ gel model naproxen. Asian Journal of Pharmacy and Technology. 2019; 9(3); DOI: 10.5958/2231-5713.2019.00034.5.
25. Jouzdani F. Wolf J. Atyabi F and Schnürch A. In situ gelling and mucoadhesive polymers: why do they need each other ? . Taylor & Francis. 2018; DOI: 10.1080/17425247.2018.1517741.
26. Gosecka M. Gosecki M. Antimicrobial Polymer-Based Hydrogels for the Intravaginal Therapies—Engineering Considerations. Pharmaceutics. 2021; 13 (1393); https://doi.org/ 10.3390/pharmaceutics13091393.
27. Liu Y. Yang F. Feng L. Yang L. Chen L. Wei G. Lu W. In vivo retention of poloxamer-based in situ hydrogels for vaginal application in mouse and rat models. Acta Pharmaceutica Sinica B. 2017; 7 (4); http://dx.doi.org/10.1016/j.apsb.2017.03.003.
28. Carvalho G. Araujo V. Santos B. Araújo J. de Souza M. Duarte J. Chorilli M. Highlights in poloxamer-based drug delivery systems as strategy at local application for vaginal infections. International Journal of Pharmaceutics. 2021; https://doi.org/10.1016/j.ijpharm.2021.120635.
29. Padmasri B. Nagaraju R. Prasanth D. A comprehensive review on in situ gels. International Journal of Applied Pharmaceutics. 2020;12 (6) DOI: http://dx.doi.org/10.22159/ijap.2020v12i6.38918.
30. Nikhar S. Bansode D. Mahadik K. Thermosensitive in situ gel of tinidazole in treatment of bacterial vaginosis: formulation and evaluation. International Journal of Ayurveda and Pharma Research. 2020; 8 (1).
31. Rencber S. Karavana S. Senyigit Z. Erac B. Limoncu M. Baloglu E. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation. Taylor and Francis. 2016; DOI: 10.3109/10837450.2016.1163385.
32. Swain G. Patel S. Gandhi J. Shah P. Development of Moxifloxacin Hydrochloride loaded in-situ gel for the treatment of periodontitis: In-vitro drug release study and antibacterial activity. Journal of Oral Biology and Craniofacial Research. 2019; https://doi.org/10.1016/j.jobcr.2019.04.001.
33. Mahajan N. Shende S. Dumore N. Nasare L. Development and evaluation of ion induced in situ gelling system of opoid analgesic for nose to brain delivery. Research Journal of Pharmacy and Technology. 2019; 12(10); DOI:10.5958/0974-360X.2019.00817.5.
34. Barrea L. Verde L. Auriemma R. Vetrani C. Cataldi M. Toral E. Pugliese G. Camajan E. Savastano S. Colao A. Muscogiuri G. Probiotics and Prebiotics: Any Role in Menopause Related Diseases?. Springer. 2023; 12; DOI: https://doi.org/10.1007/s13668-023-00462-3.
35. Hossain K. Nahar K. Shokryazdan P. Abdullah N. Hamid K. Jahromi M. Probiotic potential of lactic acid bacterial isolated from cheese, yogurt and poultry faeces. Research Journal of Pharmacy and Technology. 2017; 10 (9); DOI: 10.5958/0974-360X.2017.00530.3.
36. Sugiyartono. Purwanti T. Asega I. Influence of emcompress concentration on the physical properties of tablet containing lactobacillus spp. And guava leaves extract. Asian Journal of Pharmaceutical Research. 2014; 4(4).
37. Ladaycia A. Passirania C and Lepeltier E. Microbiota and Nanoparticles: Description and Interaction. Elsevier. 2021; 169.
38. Chauhan A. Kaur S. Singh R. A review on probiotics and fish farming. Research Journal of Pharmacy and Technology. 2018; 11(11); DOI: 10.5958/0974-360X.2018.00939.3.
39. Balogue E. Karavan S. Senyigit Z. Guner T. Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base. Informa Healthcare. 2010; 16(6) DOI:10.3109/10837450.2010.508074.
40. Abbe C and Mitchell C. Bacterial vaginosis : a review of approaches to treatment and prevention. frontiers in reproductive health. 2023; doi: 10.3389/frph.2023.1100029.
41. Ngyuyen H. Nguyen D. Nguyen T. Biological activites of poly (lactic acid) polymer produced from Lactobacillus rhamnosus PN04. Research Journal of Pharmacy and Technology. 2018; 11(7); DOI:10.5958/0974-360X.2018.00562.0.
42. You S. Ma Y. Yan B. Pei W. Wu Q. Ding C and Haung C. The promotion mechanism of prebiotics for probiotics: A review. Frontiers in Nutrition. 2022; DOI:10.3389/fnut.2022.1000517.
43. Falagas M. Betsi G. & Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis. Clinical Microbiology Infection. 2007; 13 (7);10.1111/j.1469-0691.2007.01688.x
44. Sreeja V. Prajapati J. Probiotic Formulations: Application and Status as Pharmaceuticals-A Review. Probiotics & Antimicrobiology. Proteins. 2013; DOI 10.1007/s12602-013-9126-2.
45. Lehtoranta L. Jaakkola R. Laitila R and Maukonen J. Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span. Frontiers in Microbiology. 2022; doi: 10.3389/fmicb.2022.819958.
46. Yoshikata R. Yamaguchi M. Mase Y. Tatsuyuki Y. Myint K. Ohta H. Evaluation of the efficacy of Lactobacillus containing feminine hygiene products on vaginal microbiome and genitourinary symptoms in pre- and postmenopausal women: A pilot randomized controlled trial. Plos One. 2022; 17(12); https://doi.org/10.1371/journal.pone.0270242.
47. Anh N. Yen T. Vinh D Et. Al. Study on the ability of producing of conjugated linoleic acid of lactobacillus fermemtum A01 isolated from human digestive tract. Research Journal of Pharmacy and Technology. 2021; 14(3); DOI:10.5958/0974-360X.2021.00234.1.
48. Tachedjian G. Aldunate M. Bradshaw C. Cone R. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res. Microbiology. 2017; http://dx.doi.org/10.1016/j.resmic.2017.04.001.
49. Palma E. Recine N. Domenici L. Giorgini M. Pierangeli A. Panici P. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection. BMC Infectious Diseases. 2018; 18:13; DOI 10.1186/s12879-017-2938-z.